Schedule 13D ownership disclosure

Immunoclin Corp

Security class unavailable · CUSIP: 45256L109

Event date: 2013-12-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,000,000
Percent of class
42.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-090848
Form type
SC 13D
Filer
Bray Dr Dorothy H
CIK
CIK 1621170
Filed
Mar 29, 2016
Reporting period
Dec 13, 2013
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub